Dexcom [DXCM] vs Medtronic plc [MDT] Detailed Stock Comparison

Dexcom

NASDAQ
Loading...

Medtronic plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dexcom wins in 3 metrics, Medtronic plc wins in 16 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDexcomMedtronic plcBetter
P/E Ratio (TTM)47.3926.02Medtronic plc
Price-to-Book Ratio10.182.55Medtronic plc
Debt-to-Equity Ratio100.2459.44Medtronic plc
PEG Ratio1.7116.28Dexcom
EV/EBITDA27.8515.13Medtronic plc
Profit Margin (TTM)13.29%13.63%Medtronic plc
Operating Margin (TTM)18.37%18.69%Medtronic plc
EBITDA Margin (TTM)18.37%18.69%Medtronic plc
Return on Equity22.83%9.74%Dexcom
Return on Assets (TTM)6.08%4.57%Dexcom
Free Cash Flow (TTM)$630.70M$5.19BMedtronic plc
Dividend YieldN/A3.27%N/A
1-Year Return-2.45%8.18%Medtronic plc
Price-to-Sales Ratio (TTM)6.153.57Medtronic plc
Enterprise Value$25.71B$142.89BMedtronic plc
EV/Revenue Ratio5.984.18Medtronic plc
Gross Profit Margin (TTM)59.53%65.02%Medtronic plc
Revenue per Share (TTM)$11$27Medtronic plc
Earnings per Share (Diluted)$1.41$3.66Medtronic plc
Beta (Stock Volatility)1.490.79Medtronic plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dexcom vs Medtronic plc Stock Performance Analysis

Loading Price Chart...

Dexcom
Medtronic plc
Dexcom Stock Overview | Medtronic plc Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dexcom0.54%-2.72%-10.58%-20.51%-2.49%-15.36%
Medtronic plc0.71%1.25%2.30%8.16%7.45%19.02%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dexcom-2.45%-34.95%-31.15%242.65%1,848.39%2,085.53%
Medtronic plc8.18%15.85%-12.15%31.52%185.44%78.40%

News Based Sentiment: Dexcom vs Medtronic plc

Dexcom

News based Sentiment: MIXED

Dexcom experienced a month of conflicting signals. While Q2 earnings beat expectations and revenue grew, concerns about regulatory delays, product safety allegations, and analyst downgrades created significant volatility and uncertainty, making it a mixed bag for investors.

View Dexcom News Sentiment Analysis

Medtronic plc

News based Sentiment: POSITIVE

September was a remarkably positive month for Medtronic, driven by a strong earnings beat, increased guidance, and key regulatory approvals. These developments demonstrate effective execution of strategic initiatives and reinforce the company's commitment to shareholder value, making it a compelling investment story.

View Medtronic plc News Sentiment Analysis

Performance & Financial Health Analysis: Dexcom vs Medtronic plc

MetricDXCMMDT
Market Information
Market Cap i$26.16B$121.93B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i8,183,6128,430,980
90 Day Avg. Volume i5,586,6577,487,350
Last Close$66.44$95.48
52 Week Range$57.52 - $93.25$79.29 - $96.25
% from 52W High-28.75%-0.80%
All-Time High$164.86 (Nov 15, 2021)$135.89 (Sep 06, 2021)
% from All-Time High-59.70%-29.74%
Growth Metrics
Quarterly Revenue Growth0.15%0.08%
Quarterly Earnings Growth0.25%0.00%
Financial Health
Profit Margin (TTM) i0.13%0.14%
Operating Margin (TTM) i0.18%0.19%
Return on Equity (TTM) i0.23%0.10%
Debt to Equity (MRQ) i100.2459.44
Cash & Liquidity
Book Value per Share (MRQ)$6.56$37.36
Cash per Share (MRQ)$7.47$6.33
Operating Cash Flow (TTM) i$987.70M$7.15B
Levered Free Cash Flow (TTM) i$425.12M$4.46B
Dividends
Last 12-Month Dividend Yield iN/A3.27%
Last 12-Month Dividend iN/A$2.80

Valuation & Enterprise Metrics Analysis: Dexcom vs Medtronic plc

MetricDXCMMDT
Price Ratios
P/E Ratio (TTM) i47.3926.02
Forward P/E i32.9116.28
PEG Ratio i1.7116.28
Price to Sales (TTM) i6.153.57
Price to Book (MRQ) i10.182.55
Market Capitalization
Market Capitalization i$26.16B$121.93B
Enterprise Value i$25.71B$142.89B
Enterprise Value Metrics
Enterprise to Revenue i5.984.18
Enterprise to EBITDA i27.8515.13
Risk & Other Metrics
Beta i1.490.79
Book Value per Share (MRQ) i$6.56$37.36

Financial Statements Comparison: Dexcom vs Medtronic plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DXCMMDT
Revenue/Sales i$1.04B$8.58B
Cost of Goods Sold i$447.00M$3.00B
Gross Profit i$589.00M$5.58B
Research & Development i$145.20M$726.00M
Operating Income (EBIT) i$133.70M$1.52B
EBITDA i$219.00M$2.30B
Pre-Tax Income i$154.30M$1.30B
Income Tax i$48.90M$255.00M
Net Income (Profit) i$105.40M$1.05B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DXCMMDT
Cash & Equivalents i$904.90M$2.22B
Total Current Assets i$4.55B$23.81B
Total Current Liabilities i$3.04B$12.88B
Long-Term Debt i$1.36B$25.64B
Total Shareholders Equity i$2.27B$48.26B
Retained Earnings i$1.70B$31.48B
Property, Plant & Equipment i$59.10M$7.16B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DXCMMDT
Operating Cash Flow i$167.90M$2.14B
Capital Expenditures i$-87.00M$-459.00M
Free Cash Flow i$96.80M$2.07B
Debt Repayment iN/AN/A
Common Stock Repurchase iN/A$-274.00M

Short Interest & Institutional Ownership Analysis

MetricDXCMMDT
Shares Short i13.14M12.79M
Short Ratio i3.181.78
Short % of Float i0.04%0.01%
Average Daily Volume (10 Day) i8,183,6128,430,980
Average Daily Volume (90 Day) i5,586,6577,487,350
Shares Outstanding i390.70M1.28B
Float Shares i389.52M1.28B
% Held by Insiders i0.00%0.00%
% Held by Institutions i0.97%0.87%

Dividend Analysis & Yield Comparison: Dexcom vs Medtronic plc

MetricDXCMMDT
Last 12-Month Dividend iN/A$2.80
Last 12-Month Dividend Yield iN/A3.27%
3-Year Avg Annual Dividend iN/A$2.76
3-Year Avg Dividend Yield iN/A0.83%
3-Year Total Dividends iN/A$8.28
Ex-Dividend DateN/AMar 28, 2025